Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Signal transduction: multiple pathways, multiple options for therapy.

C H Heldin1

  • 1Ludwig Institute for Cancer Research, Biomedical Center, Uppsala, Sweden. C-H.Heldin@LICR.uu.se

Stem Cells (Dayton, Ohio)
|July 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smad regulation in TGF-beta signal transduction.

Journal of cell science·2002
Same author

Signal transduction. RIPping tyrosine kinase receptors apart.

Science (New York, N.Y.)·2001
Same author

Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.

The EMBO journal·2001
Same author

Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.

Cancer research·2001
Same author

Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation.

American journal of respiratory cell and molecular biology·2001
Same author

Ligand stimulation reduces platelet-derived growth factor beta-receptor susceptibility to tyrosine dephosphorylation.

The Journal of biological chemistry·2001
Same journal

Brent A. Reynolds, pioneer of adult neural stem cell biology.

Stem cells (Dayton, Ohio)·2026
Same journal

CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.

Stem cells (Dayton, Ohio)·2026
Same journal

Transforming Growth Factor beta-2 (TGFβ2) Drives Trabecular Meshwork Progenitor Cell Differentiation Through SMAD2/3 Signalling.

Stem cells (Dayton, Ohio)·2026
Same journal

Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.

Stem cells (Dayton, Ohio)·2026
Same journal

Regeneration of the mammalian brain: a relic of evolution?

Stem cells (Dayton, Ohio)·2026
Same journal

Mitochondrial transfer technologies with molecular insights into clinical applications.

Stem cells (Dayton, Ohio)·2026
See all related articles

Cellular processes like growth and differentiation are controlled by environmental signals. Disruptions in these signaling pathways are linked to diseases, making pathway antagonists potential therapeutic agents.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Disease Pathogenesis

Background:

  • Cell behavior (growth, motility, differentiation, apoptosis) is regulated by environmental signals.
  • These signals are crucial for embryonal development, wound healing, hematopoiesis, and immune response.
  • Signals originate from cell-cell interactions, extracellular matrix components, or soluble molecules binding to cell membrane receptors.

Purpose of the Study:

  • To explore the role of environmental signals in regulating cell behavior.
  • To investigate the link between signaling pathway perturbations and diseases.
  • To highlight the clinical potential of signaling pathway antagonists.

Main Methods:

  • Analysis of cell signaling pathways.
  • Review of disease mechanisms involving signaling perturbations.

Related Experiment Videos

  • Examination of existing and emerging therapeutic antagonists.

    • Main Results:

    • Environmental signals initiate diverse intracellular signaling pathways.
    • Dysregulation of these pathways is implicated in cancer, inflammation, and atherosclerosis.
    • Numerous signaling pathway antagonists are in clinical use or trials, with others under investigation.

    Conclusions:

    • Cellular signaling is fundamental to normal physiological processes.
    • Aberrant signaling pathways are key drivers in various pathologies.
    • Targeting these pathways with antagonists offers significant therapeutic promise.